TEAD1 protects against necroptosis in postmitotic cardiomyocytes through regulation of nuclear DNA-encoded mitochondrial genes
- 19 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 28 (7), 2045-2059
- https://doi.org/10.1038/s41418-020-00732-5
Abstract
The Hippo signaling effector, TEAD1 plays an essential role in cardiovascular development. However, a role for TEAD1 in postmitotic cardiomyocytes (CMs) remains incompletely understood. Herein we reported that TEAD1 is required for postmitotic CM survival. We found that adult mice with ubiquitous or CM-specific loss of Tead1 present with a rapid lethality due to an acute-onset dilated cardiomyopathy. Surprisingly, deletion of Tead1 activated the necroptotic pathway and induced massive cardiomyocyte necroptosis, but not apoptosis. In contrast to apoptosis, necroptosis is a pro-inflammatory form of cell death and consistent with this, dramatically higher levels of markers of activated macrophages and pro-inflammatory cytokines were observed in the hearts of Tead1 knockout mice. Blocking necroptosis by administration of necrostatin-1 rescued Tead1 deletion-induced heart failure. Mechanistically, genome-wide transcriptome and ChIP-seq analysis revealed that in adult hearts, Tead1 directly activates a large set of nuclear DNA-encoded mitochondrial genes required for assembly of the electron transfer complex and the production of ATP. Loss of Tead1 expression in adult CMs increased mitochondrial reactive oxygen species, disrupted the structure of mitochondria, reduced complex I-IV driven oxygen consumption and ATP levels, resulting in the activation of necroptosis. This study identifies an unexpected paradigm in which TEAD1 is essential for postmitotic CM survival by maintaining the expression of nuclear DNA-encoded mitochondrial genes required for ATP synthesis.Keywords
Funding Information
- American Heart Association (19POST34450071, 17EIA33460468, 19TPA34910181)
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K99HL153896, R01HL132182, R01HL149995)
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
This publication has 51 references indexed in Scilit:
- Direct, Differential Effects of Tamoxifen, 4-Hydroxytamoxifen, and Raloxifene on Cardiac Myocyte Contractility and Calcium HandlingPLOS ONE, 2013
- TEAD4 establishes the energy homeostasis essential for blastocoel formationDevelopment, 2013
- Control of mitochondrial structure and function by the Yorkie/YAP oncogenic pathwayGenes & Development, 2012
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Molecular mechanisms of necroptosis: an ordered cellular explosionNature Reviews Molecular Cell Biology, 2010
- TEAD-1 Overexpression in the Mouse Heart Promotes an Age-dependent Heart DysfunctionOnline Journal of Public Health Informatics, 2010
- Avoidance of Transient Cardiomyopathy in Cardiomyocyte-Targeted Tamoxifen-Induced MerCreMer Gene Deletion ModelsCirculation Research, 2009
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced InflammationCell, 2009
- How dying cells alert the immune system to dangerNature Reviews Immunology, 2008
- Necrostatin: A Potentially Novel Cardioprotective Agent?Cardiovascular Drugs and Therapy, 2007